April 28, 2014

OPINION: Evidence Vital to Tobacco Debate

  OUR LATEST ON TWITTER

Global Innovation Policy Center @globalIPcenter 21h

“Waiving drug companies' intellectual property rights risks setting a bad precedent for future investment in new drugs. And that risk may not be worth it without additional steps to meaningfully increase the availability of shots across the world.” https://t.co/UE6nqe8Cyb

Reply Retweet Favorite


Subscribe for updates from GIPC